scholarly journals VP18.10: What is the benefit of using an ultrasound checklist during a second trimester screening exam?

2021 ◽  
Vol 58 (S1) ◽  
pp. 175-175
Author(s):  
B. Deloison ◽  
G. Benoit ◽  
C. Bernabe Dupont ◽  
A. Sabine ◽  
F. Jacquemard ◽  
...  
Keyword(s):  
Second Trimester ◽  
Second Trimester Screening ◽  
Trimester Screening

scholarly journals P25.03: Effect of IVF/ICSI on second trimester screening markers

2012 ◽  
Vol 40 (S1) ◽  
pp. 264-264
Author(s):  
E. Colantuono ◽  
F. D'Antonio ◽  
M. Recchi ◽  
L. Marrone ◽  
B. Matarrelli ◽  
...  
Keyword(s):  
Second Trimester ◽  
Second Trimester Screening ◽  
Trimester Screening

Agenesis of ductus venosus in sequential first and second trimester screening

2014 ◽  
Vol 34 (11) ◽  
pp. 1099-1105 ◽  
Author(s):  
D. G. Iliescu ◽  
M. L. Cara ◽  
S. Tudorache ◽  
P. Antsaklis ◽  
L. V. Novac ◽  
...  
Keyword(s):  
Ductus Venosus ◽  
Second Trimester ◽  
Second Trimester Screening ◽  
Trimester Screening

scholarly journals The Effect of Down Syndrome Biochemical Markers on Predicting Severity of Preeclampsia

2020 ◽  
Author(s):  
AYSE OZBAN
Keyword(s):  
Down Syndrome ◽  
Pregnant Women ◽  
Biochemical Markers ◽  
First Trimester ◽  
Maternal Serum ◽  
Screening Tests ◽  
Second Trimester ◽  
Study Results ◽  
Second Trimester Screening ◽  
Trimester Screening

Abstract Objective: This study aims to determine whether it is possible to predict preeclampsia by comparing postpartum results and test results of the pregnant women diagnosed with preeclampsia, whose first and/or second trimester screening tests were accessible, and to demonstrate the predictability of severity and week of onset.Background: 204 patients underwent renal transplantation in our center and 84 of them were female. Five of our patients (one of them had two births) gave birth to a total of 6 pregnancies.Method: 135 patients were diagnosed with preeclampsia and their first and/or second trimester screening tests were accessible, and 366 control participants gave birth to a healthy baby between 37-41 weeks after standard follow-up period for pregnancy and their screening tests were also accessible.Results: The study results show that the first trimester maternal serum PAPP-A level is significantly low in preeclamptic pregnant women, and that the second trimester maternal serum AFP and hCG levels are significantly high and uE3 levels are significantly low The results also suggest that the first and second trimester Down syndrome biochemical markers can be used in preeclampsia screening.Conclusion: Among these markers, uE3 is the parameter which affects the possibility of preeclampsia the most. However, the first and second trimester Down syndrome biochemical markers are not effective in predicting the severity and onset week of preeclampsia.

scholarly journals Second Trimester Screening of Congenital Heart Disease

2012 ◽  
pp. 8-19
Author(s):  
Giovanna Ogge ◽  
Pietro Gaglioti ◽  
Manuela Oberto ◽  
Tullia Todros
Keyword(s):  
Congenital Heart Disease ◽  
Heart Disease ◽  
Congenital Heart ◽  
Second Trimester ◽  
Second Trimester Screening ◽  
Trimester Screening
Sign in / Sign up

Export Citation Format

Share Document